Saturday, March 25, 2023 | Back issues
Courthouse News Service Courthouse News Service


SmithKlineBeecham knew but failed to warn that its diabetes drug Rosiglitazone, aka Avandia, Amaryl and Avandaryl, could cause heart attacks, strokes and death, a class-action complaint claims in Sacramento Federal Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.